TIVC — Tivic Health Systems Share Price
Last trade - 00:00- $3.68m
- $0.23m
- $0.78m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | 1.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.64 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -133.54% | ||
| Return on Equity | -178.18% | ||
| Operating Margin | -1548.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.86 | 1.26 | 1.84 | 1.18 | 0.78 | 8.03 | n/a | 13.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tivic Health Systems, Inc. is a late-stage therapeutics company. The Company’s biopharma program is focused on advancing its drug product candidate, Entolimod, into manufacturing, conducting process validation utilizing the output of such manufacturing with the intent of selling the biologic compounds either inside or outside the United States. The Company’s bioelectronic program is focused on developing non-invasive medical devices that influence biologic functions associated with various diseases and conditions. It has an over-the-counter device, ClearUP, that treats sinus pain and pressure. The Company’s Toll-like Receptor 5 (TLR5) program’s lead product candidate is the late-stage TLR5 agonist, Entolimod, to treat acute radiation syndrome (ARS) and for remediating side effects of medical radiation and chemotherapy. The Company offers contract development and manufacturing organization through its subsidiary Velocity Bioworks, Inc.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- June 7th, 2021
- Public Since
- November 11th, 2021
- No. of Shareholders
- 120
- No. of Employees
- 7
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 1,765,952
- Address
- 47685 Lakeview Blvd, FREMONT, 94538
- Web
- https://tivichealth.com/
- Phone
- Contact
- Jim Hock
- Auditors
- ROSENBERG RICH BAKER BERMAN, P.A.
Upcoming Events for TIVC
Similar to TIVC
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
Alpha Tau Medical
NASDAQ Capital Market
FAQ
As of Today at 22:43 UTC, shares in Tivic Health Systems are trading at $2.09. This share price information is delayed by 15 minutes.
Shares in Tivic Health Systems last closed at $2.09 and the price had moved by -45.9% over the past 365 days. In terms of relative price strength the Tivic Health Systems share price has underperformed the S&P500 Index by -52.05% over the past year.
There is no consensus recommendation for this security.
Find out moreTivic Health Systems does not currently pay a dividend.
Tivic Health Systems does not currently pay a dividend.
Tivic Health Systems does not currently pay a dividend.
To buy shares in Tivic Health Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.09, shares in Tivic Health Systems had a market capitalisation of $3.68m.
Here are the trading details for Tivic Health Systems:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: TIVC
Based on an overall assessment of its quality, value and momentum Tivic Health Systems is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Tivic Health Systems is $210.00. That is 9971.94% above the last closing price of $2.09.
Analysts covering Tivic Health Systems currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tivic Health Systems. Over the past six months, its share price has underperformed the S&P500 Index by -50.34%.
As of the last closing price of $2.09, shares in Tivic Health Systems were trading -39.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tivic Health Systems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tivic Health Systems' management team is headed by:
- Jennifer Ernst - CEO
- John Claude - CFD
- Ryan Sabia - COO
- Blake Gurfein - CSO
- Subinoy Das - EXO